Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5203 studies found for:    Lymphoma
Show Display Options
Rank Status Study
1 Completed
Has Results
Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)
Condition: Lymphoma
Interventions: Drug: Temsirolimus (CCI-779);   Drug: Investigator's choice
2 Completed Velcade in MALT Lymphoma Patients
Condition: MALT Lymphoma
Intervention: Drug: Bortezomib (Velcade)
3 Unknown  Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: alemtuzumab;   Biological: donor lymphocytes;   Drug: carmustine;   Drug: cytarabine;   Drug: etoposide;   Drug: melphalan;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
4 Withdrawn Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma
Condition: Lymphoma
Interventions: Biological: anti-thymocyte globulin;   Biological: therapeutic allogeneic lymphocytes;   Drug: cyclophosphamide;   Drug: cyclosporine;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
5 Completed Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: bortezomib;   Drug: gemcitabine hydrochloride
6 Active, not recruiting Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma
Condition: Lymphoma
Interventions: Drug: rituximab;   Drug: bortezomib;   Drug: Ibritumomab tiuxetan
7 Completed Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma
Condition: Lymphoma
Interventions: Biological: bevacizumab;   Biological: filgrastim;   Biological: pegfilgrastim;   Drug: bortezomib;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ganciclovir;   Drug: valganciclovir;   Drug: zidovudine
8 Completed Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: bortezomib;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisolone;   Drug: vincristine sulfate;   Other: questionnaire administration;   Procedure: quality-of-life assessment
9 Unknown  Trial of Lenalidomide in Patients With Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) Type
Condition: MALT Lymphoma
Intervention: Drug: Lenalidomide
10 Completed Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Drug: CHOP regimen;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: prednisone;   Drug: vincristine sulfate;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
11 Completed SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Condition: Lymphoma
Intervention: Other: biologic sample preservation procedure
12 Completed Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: bendamustine hydrochloride;   Drug: lenalidomide
13 Unknown  Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Biological: recombinant interferon alfa;   Drug: carmustine;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: dexamethasone;   Drug: etoposide;   Drug: melphalan;   Procedure: bone marrow ablation with stem cell support;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
14 Completed Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
Condition: Lymphoma
Interventions: Drug: Amoxicillin;   Drug: Bismuth Subsalicylate;   Drug: Clarithromycin;   Drug: Metronidazole Hydrochloride;   Drug: Omeprazole;   Drug: Tetracycline Hydrochloride
15 Completed Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: aldesleukin;   Biological: filgrastim;   Biological: recombinant interferon alfa;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: doxorubicin hydrochloride;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: prednisone;   Drug: teniposide;   Drug: vincristine sulfate;   Procedure: allogeneic bone marrow transplantation;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
16 Completed
Has Results
GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Biological: rituximab;   Biological: sargramostim;   Drug: carmustine;   Drug: cytarabine;   Drug: etoposide;   Drug: melphalan;   Procedure: autologous hematopoietic stem cell transplantation
17 Terminated
Has Results
Vaccine Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: autologous tumor cell vaccine;   Biological: keyhole limpet hemocyanin;   Biological: sargramostim;   Procedure: adjuvant therapy
18 Completed Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: aldesleukin;   Biological: rituximab;   Biological: therapeutic autologous lymphocytes;   Drug: fludarabine phosphate
19 Completed Treatment of Mature B-cell Lymphoma/Leukaemia
Condition: B-Cell Lymphoma
Interventions: Drug: half cyclophosphamide;   Drug: without COPADM3;   Drug: mini CYVE, without 3 maintenance courses;   Drug: LMB B;   Drug: LMB C
20 Completed Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Biological: rituximab;   Drug: carmustine;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: etoposide;   Drug: melphalan;   Procedure: bone marrow ablation with stem cell support;   Procedure: peripheral blood stem cell transplantation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.